These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20014353)

  • 1. Sample size requirement to detect an intervention effect at the end of follow-up in a longitudinal cluster randomized trial.
    Heo M; Kim Y; Xue X; Kim MY
    Stat Med; 2010 Feb; 29(3):382-90. PubMed ID: 20014353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical power and sample size requirements for three level hierarchical cluster randomized trials.
    Heo M; Leon AC
    Biometrics; 2008 Dec; 64(4):1256-62. PubMed ID: 18266889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size requirements to detect an intervention by time interaction in longitudinal cluster randomized clinical trials.
    Heo M; Leon AC
    Stat Med; 2009 Mar; 28(6):1017-27. PubMed ID: 19153969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
    Fazzari MJ; Kim MY; Heo M
    J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample sizes required to detect two-way and three-way interactions involving slope differences in mixed-effects linear models.
    Heo M; Leon AC
    J Biopharm Stat; 2010 Jul; 20(4):787-802. PubMed ID: 20496206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varying cluster sizes in trials with clusters in one treatment arm: sample size adjustments when testing treatment effects with linear mixed models.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2009 Aug; 28(18):2307-24. PubMed ID: 19472169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of subject attrition on sample size determinations for longitudinal cluster randomized clinical trials.
    Heo M
    J Biopharm Stat; 2014; 24(3):507-22. PubMed ID: 24697555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical power and sample size requirements to detect an intervention by time interaction in four-level longitudinal cluster randomized trials.
    Ghosh S; Mukhopadhyay S; Majumder P; Wang B
    Stat Med; 2022 Jun; 41(14):2542-2556. PubMed ID: 35441378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size determinations for stepped-wedge clinical trials from a three-level data hierarchy perspective.
    Heo M; Kim N; Rinke ML; Wylie-Rosett J
    Stat Methods Med Res; 2018 Feb; 27(2):480-489. PubMed ID: 26988927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size determination for constrained longitudinal data analysis.
    Lu K; Mehrotra DV; Liu G
    Stat Med; 2009 Feb; 28(4):679-99. PubMed ID: 19051207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating cost in power analysis for three-level cluster-randomized designs.
    Konstantopoulos S
    Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size in cluster-randomized trials with time to event as the primary endpoint.
    Jahn-Eimermacher A; Ingel K; Schneider A
    Stat Med; 2013 Feb; 32(5):739-51. PubMed ID: 22865817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size adjustments for varying cluster sizes in cluster randomized trials with binary outcomes analyzed with second-order PQL mixed logistic regression.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2010 Jun; 29(14):1488-501. PubMed ID: 20101669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes.
    Chakraborty H; Moore J; Hartwell TD
    Contemp Clin Trials; 2009 Sep; 30(5):473-80. PubMed ID: 19386285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a mixed effects logistic regression model for binary outcomes with unequal cluster size.
    Heo M; Leon AC
    J Biopharm Stat; 2005; 15(3):513-26. PubMed ID: 15920895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing completely and stratified randomized designs in cluster randomized trials when the stratifying factor is cluster size: a simulation study.
    Lewsey JD
    Stat Med; 2004 Mar; 23(6):897-905. PubMed ID: 15027079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.